Oncolys BioPharma Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	28.55	31.38	63.04	976.18	642.49	314.18
Revenue Growth (YoY)	-9.04%	-50.21%	-93.54%	51.94%	104.50%	-75.90%
Cost of Revenue	-	-	32.43	637.7	443.69	78.07
Gross Profit	28.55	31.38	30.61	338.49	198.8	236.11
Selling, General & Admin	2,051	1,713	1,961	1,543	1,653	1,911
Operating Expenses	2,060	1,719	1,961	1,561	1,722	1,925
Operating Income	-2,031	-1,688	-1,931	-1,222	-1,523	-1,689
Interest Expense	-4.95	-4.6	-3.6	-3.95	-4.17	-4.17
Interest & Investment Income	3.87	2.15	1.48	0.59	0.5	0.57
Currency Exchange Gain (Loss)	11.19	43.78	27.6	62.64	37.37	-17.56
Other Non Operating Income (Expenses)	-13.37	-17.63	-8.68	0.01	-11.51	-13.83
EBT Excluding Unusual Items	-2,035	-1,664	-1,914	-1,163	-1,501	-1,724
Gain (Loss) on Sale of Investments	-	-	-	21.41	-90.98	-321
Gain (Loss) on Sale of Assets	-	-	0.14	-	-	-
Asset Writedown	-17.1	-17.1	-21.9	-4.4	-19.85	-11.14
Other Unusual Items	-	-	-	-	-	-35.68
Pretax Income	-2,052	-1,681	-1,936	-1,146	-1,612	-2,091
Income Tax Expense	3.41	3.76	2.93	2.93	3.73	3.73
Net Income	-2,055	-1,685	-1,939	-1,149	-1,615	-2,095
Net Income to Common	-2,055	-1,685	-1,939	-1,149	-1,615	-2,095
Shares Outstanding (Basic)	25	22	18	17	17	14
Shares Outstanding (Diluted)	25	22	18	17	17	14
Shares Change (YoY)	21.76%	22.67%	2.71%	2.44%	17.54%	3.41%
EPS (Basic)	-82.55	-77.17	-108.92	-66.31	-95.50	-145.58
EPS (Diluted)	-82.55	-77.17	-108.92	-66.31	-95.50	-145.58
Free Cash Flow	-	-2,024	-1,343	-1,718	-1,743	-1,468
Free Cash Flow Per Share	-	-92.69	-75.44	-99.18	-103.06	-102.00
Gross Margin	100.00%	100.00%	48.55%	34.67%	30.94%	75.15%
Operating Margin	-7116.10%	-5377.29%	-3062.62%	-125.21%	-237.06%	-537.45%
Profit Margin	-7199.36%	-5368.27%	-3075.14%	-117.70%	-251.43%	-666.85%
Free Cash Flow Margin	-	-6447.89%	-2129.84%	-176.04%	-271.33%	-467.22%
EBITDA	-2,032	-1,687	-1,928	-1,221	-1,517	-1,684
EBITDA Margin	-	-	-	-125.12%	-236.05%	-
D&A For EBITDA	-0.29	0.82	2.29	0.91	6.49	4.89
EBIT	-2,031	-1,688	-1,931	-1,222	-1,523	-1,689
EBIT Margin	-	-	-	-125.21%	-237.06%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.